Sign in

CIK 0001393434

  • Large accelerated filer

OCULAR THERAPEUTIX, INC

Sign in to watch
Ticker
OCUL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 781-357-4000
Business address
14 CROSBY DRIVE, 3RD FLOOR, BEDFORD, MA, 01730
Former names
I-THERAPEUTIX INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$799,174
in 9 filings, $788K under 10b5-1 plans

Net −$799,174. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-06-14 Heier Jeffrey S. Director Grant or award · Stock Option (Right to Buy) +36,000 36,000
2023-02-06 White Christopher G Chief Business Officer Sale −5,829 $4.24 $25K 94,766
2023-02-06 Ozden Rabia Gurses Chief Medical Officer Sale −6,416 $4.24 $27K 101,363
2023-02-06 Notman Donald Chief Financial Officer Sale −6,476 $4.24 $27K 139,387
2023-02-06 Strassburger Philip C. General Counsel Sale −6,181 $4.24 $26K 109,071
2023-02-06 Mattessich Antony C. President and CEO Sale −19,669 $4.24 $83K 446,281
2023-01-30 White Christopher G Chief Business Officer Grant or award +44,444 100,595
2023-01-30 White Christopher G Chief Business Officer Grant or award · Stock Option (Right to Buy) +133,333 133,333
2023-01-30 Strassburger Philip C. General Counsel Grant or award +55,556 115,252
2023-01-30 Strassburger Philip C. General Counsel Grant or award · Stock Option (Right to Buy) +166,667 166,667
2023-01-30 Ozden Rabia Gurses Chief Medical Officer Grant or award +55,556 107,779
2023-01-30 Ozden Rabia Gurses Chief Medical Officer Grant or award · Stock Option (Right to Buy) +166,667 166,667
2023-01-30 Ozden Rabia Gurses Chief Medical Officer Grant or award · Stock Option (Right to Buy) +50,000 50,000
2023-01-30 Notman Donald Chief Financial Officer Grant or award +55,556 145,863
2023-01-30 Notman Donald Chief Financial Officer Grant or award · Stock Option (Right to Buy) +166,667 166,667
2023-01-30 Mattessich Antony C. President and CEO Grant or award +176,300 465,950
2023-01-30 Mattessich Antony C. President and CEO Grant or award · Stock Option (Right to Buy) +536,900 536,900
2022-11-07 SUMMER ROAD LLC 10% owner Purchase +7,328 $3.50 $26K 6,122,089
2022-10-17 Heier Jeffrey S. Director Grant or award · Stock Option (Right to Buy) +16,000 16,000
2022-10-13 White Christopher G Chief Business Officer Grant or award · Stock Option (Right to Buy) +7,000 7,000

Page 11 of 17 · 327 trades